Iranpharmis
Fa

IranPharmis’ Participation in “the 17th International Congress of Anesthesiology, Intensive Care, and Pain”

IranPharmis’ Participation in “the 17th International Congress of Anesthesiology, Intensive Care, and Pain”

IranPharmis’ Participation in the 17th International Congress of Anesthesiology, Intensive Care, and Pain

 

Event Overview

 The International Congress of Anesthesiology, Intensive Care, and Pain is regarded as one of the country’s most reputable scientific events. It is held annually with the participation of leading professors, specialist physicians, and companies active in the medical equipment sector.

“The 17th edition of this congress was held from November 5 to 7, 2025 (14–16 Aban 1404) at the “International Conference Center of Shahid Beheshti University of Medical Sciences (Aburayhan)”, where the latest scientific achievements and innovative technologies related to anesthesia and intensive care were reviewed.

IranPharmis participated actively and purposefully in this congress with the aim of introducing specialized equipment and exchanging technical knowledge.

 

IranPharmis’ Objectives for Participating in the Congress

 By attending this congress, IranPharmis emphasized its commitment to innovation in therapeutic technologies and its support for the community of anesthesia and intensive care specialists.

The main objectives of this participation included:

 

o   Introducing new and efficient equipment in the fields of respiration, anesthesia, and vascular access

o   Exchanging technical and scientific knowledge with national and international specialists

o   Gaining insight into the current needs of the medical community to enhance products

o   Developing scientific and hospital collaborations to improve treatment standards

 

IranPharmis’ Activities and Achievements

 During the three-day event, IranPharmis showcased a range of its key equipment at a specialized booth, which attracted significant attention from professors, anesthesia and intensive care specialists, and ICU nurses.

 

Some of IranPharmis’ notable activities at the congress included:

The presence of technical and scientific experts at the booth to provide specialized consultation to physicians and hospital managers.

·         Introducing anesthesia and respiratory equipment featuring state-of-the-art technology

·         Providing educational brochures and technical information to further familiarize specialists with the products

·         Engaging in discussions and exchanges of views on challenges related to patient safety during anesthesia and intensive care processes

 

Introduction of Presented Products

At this congress, IranPharmis introduced a selection of its products in two main categories:

Respiratory and Anesthesia Equipment

Including anesthesia systems, respiratory masks, breathing circuits, and airflow control equipment, designed to enhance patient safety and improve operational accuracy in operating rooms.

Vascular Access Products

Including various types of high-quality catheters and infusion sets, aimed at facilitating treatment procedures and reducing the risk of hospital-acquired infections.

 

Interactions and Feedback

Throughout the congress, the IranPharmis booth became one of the most visited areas of the event.

Professors, physicians, and experts praised the high quality, ergonomic design, and precise performance of IranPharmis equipment during their visits.

The feedback received from specialists indicated that the company’s equipment can play a significant role in improving the quality of services in operating rooms and intensive care units.

 

Future Outlook

Participation in the 17th International Congress of Anesthesiology, Intensive Care, and Pain once again demonstrated IranPharmis’ commitment to innovation, quality, and collaboration with the country’s medical community.

Moving forward, with a strong focus on research and development, IranPharmis aims to introduce new products based on the needs of anesthesia and intensive care specialists and to play an effective role in enhancing national treatment standards.

To learn more about IranPharmis’ specialized anesthesia, respiratory and vascular access equipment and to view detailed product information, please visit the IranPharmis Products page

10 November 2025

Related Articles

Design by: Radcom